245 related articles for article (PubMed ID: 27779165)
1. Independent Prognostic Value of High-sensitivity C-reactive Protein in Patients with Coronary Artery Ectasia.
Wang Y; Wang Y; You S; Wang H; Yin D; Dou K; Song W
Chin Med J (Engl); 2016 Nov; 129(21):2582-2588. PubMed ID: 27779165
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
3. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
4. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.
Ozbay Y; Akbulut M; Balin M; Kayancicek H; Baydas A; Korkmaz H
Mediators Inflamm; 2007; 2007():89649. PubMed ID: 17497040
[TBL] [Abstract][Full Text] [Related]
5. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
6. Elevated high sensitivity C-reactive protein and uric acid levels in coronary artery ectasia.
Demir Ş; Karakoyun G; Kanadasi M
Acta Biochim Pol; 2014; 61(4):687-91. PubMed ID: 25285332
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
Huang W; Chen QW; Lei H; Deng W; Ke DZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
[TBL] [Abstract][Full Text] [Related]
8. Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study).
Sigurdardottir FD; Lyngbakken MN; Holmen OL; Dalen H; Hveem K; Røsjø H; Omland T
Am J Cardiol; 2018 Apr; 121(8):949-955. PubMed ID: 29496193
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of high sensitivity C-reactive protein in three-vessel disease patients with and without type 2 diabetes.
Guo L; Lv H; Wang J; Zhang B; Zhu Y; Zhang X; Zhu H; Zhou X; Xia Y
Cardiovasc Diabetol; 2023 Apr; 22(1):91. PubMed ID: 37081535
[TBL] [Abstract][Full Text] [Related]
10. Gamma glutamyltransferase, inflammation and cardiovascular risk factors in isolated coronary artery ectasia.
Dogan A; Arslan A; Yucel H; Aksoy F; Icli A; Ozaydin M; Varol E; Erdogan D
Rev Port Cardiol; 2016 Jan; 35(1):33-9. PubMed ID: 26711537
[TBL] [Abstract][Full Text] [Related]
11. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
[TBL] [Abstract][Full Text] [Related]
13. [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].
Kiliç T; Ural E; Oner G; Sahin T; Kiliç M; Yavuz S; Kanko M; Kahraman G; Bildirici U; Berki KT; Ural D
Anadolu Kardiyol Derg; 2009 Aug; 9(4):280-9. PubMed ID: 19666429
[TBL] [Abstract][Full Text] [Related]
14. Incremental prognostic value of high-sensitive C-reactive protein in patients undergoing coronary computed tomography angiography.
Seo WW; Kim HL; Kim YJ; Yoon YE; Lee SP; Kim HK; Cho GY; Zo JH; Choi DJ; Sohn DW
J Cardiol; 2016 Sep; 68(3):222-8. PubMed ID: 26481470
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
[TBL] [Abstract][Full Text] [Related]
16. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
[TBL] [Abstract][Full Text] [Related]
18. Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.
Mody P; Joshi PH; Khera A; Ayers CR; Rohatgi A
J Am Coll Cardiol; 2016 May; 67(21):2480-7. PubMed ID: 27230043
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of High-Sensitivity C-Reactive Protein in Patients with Preserved Renal Function Following Percutaneous Coronary Intervention.
Shimizu T; Suwa S; Dohi T; Wada H; Miyauchi K; Shitara J; Endo H; Doi S; Ogita M; Kasai T; Okazaki S; Isoda K; Daida H
Int Heart J; 2019 Sep; 60(5):1037-1042. PubMed ID: 31484863
[TBL] [Abstract][Full Text] [Related]
20. Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).
de Martino M; Klatte T; Seemann C; Waldert M; Haitel A; Schatzl G; Remzi M; Weibl P
BJU Int; 2013 Jun; 111(8):E348-53. PubMed ID: 23495750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
